Implantable device gives electrical stimulation without battery
Scientists have created an implantable device that can provide electrical stimulation in the body without need for a battery. The…
Articles by Marisa Wexler, MS
Afzelin, a plant compound, shows neuroprotective potential in study
A plant compound called afzelin lessened motor abnormalities in a rat model of Parkinson’s disease, a study reports. Afzelin,…
Four-step method proposed to test chemicals’ Parkinson’s risk
A team led by scientists in the Netherlands is proposing a new screening strategy to test whether pesticides or other…
Top 10 Parkinson’s stories of 2023
Throughout 2023, we at Parkinson’s News Today brought you coverage of the latest scientific advances and developments in treatments for…
American football, parkinsonism link ‘inconclusive,’ study finds
American football players at the professional level may be more likely to have symptoms similar to those seen in…
New research into brain circuits could improve DBS for Parkinson’s
Researchers have figured out a new way to predict how brain cells communicate, which may have important implications for how…
Nuplazid effectively treats psychosis in Parkinson’s dementia patients
Nuplazid (pimavanserin) outperformed a placebo at managing psychosis in people with Parkinson’s disease dementia in a Phase 3…
New technique may aid Parkinson’s cell therapies’ efficiency
Scientists have developed a more efficient method for using stem cells to create new dopaminergic neurons, the dopamine-making nerve cells…
MTX325 moving into clinical testing in the coming months
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has given Mission Therapeutics clearance to launch a Phase 1 clinical…
Tiny pieces of discarded plastics like styrofoam may promote Parkinson’s
Nanoplastics — very tiny particles found in the environment when plastic breaks down — that reach a person’s brain can…